Concepedia

Christine J. Weegink

CJ

34

Publications

3K

Citations

25

H-Index

1993

Active since

Affiliations

Amsterdam UMC Location University of Amsterdam(Current)

University of Amsterdam

GGD Amsterdam

Erasmus MC

Vertex Pharmaceuticals (United States)

Christine J. Weegink is an author at Amsterdam UMC Location University of Amsterdam specializing in hepatitis, viral hepatitis, and medicine.

Top concepts

Publications per year

1993–2013

34

Publications

34

Dynamic Hepatitis C Virus Genotypic and Phenotypic Changes in Patients Treated With the Protease Inhibitor Telaprevir

Christoph Sarrazin, Tara L. Kieffer, Doug J. Bartels et al. · Gastroenterology · 2007 · 611 citations

, , +11

Rapid Decline of Viral RNA in Hepatitis C Patients Treated With VX-950: A Phase Ib, Placebo-Controlled, Randomized Study

Hendrik W. Reesink, Stefan Zeuzem, Christine J. Weegink et al. · Gastroenterology · 2006 · 394 citations

, , +9

Ribavirin treatment for patients with chronic hepatitis C: results of a placebo-controlled study

Geoffrey Dusheiko, Janice Main, H. C. Thomas et al. · Journal of Hepatology · 1996 · 352 citations

, , +7

Antiviral activity of telaprevir (VX-950) and peginterferon alfa-2a in patients with hepatitis C

Nicole Forestier, Hendrik W. Reesink, Christine J. Weegink et al. · Hepatology · 2007 · 253 citations

Sexual transmission of hepatitis C virus

Dorine Bresters, H. W. Reesink, C.L. van der Poel et al. · The Lancet · 1993 · 231 citations

, , +6

Rows per page

1–5 of 34